Optimizing in vitro culture conditions leads to a significantly shorter production time of human dermo-epidermal skin substitutes

Introduction Autologous dermo-epidermal skin substitutes (DESS) generated in vitro represent a promising therapeutic means to treat full-thickness skin defects in clinical practice. A serious drawback with regard to acute patients is the relatively long production time of 3–4 weeks. With this experimental study we aimed to decrease the production time of DESS without compromising their quality.